Cargando…
Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19
BACKGROUND AND AIMS: Currently, there are no definitive therapies for coronavirus disease 2019 (COVID-19). Gut microbial dysbiosis has been proved to be associated with COVID-19 severity and probiotics is an adjunctive therapy for COIVD-19. However, the potential benefit of probiotics in COVID-19 ha...
Autores principales: | Zhang, Lina, Han, Huanqin, Li, Xuan, Chen, Caozhen, Xie, Xiaobing, Su, Guomei, Ye, Shicai, Wang, Cuili, He, Qing, Wang, Fang, Huang, Fang, Wang, Zhaoqin, Wu, Jiayuan, Lai, Tianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351028/ https://www.ncbi.nlm.nih.gov/pubmed/34394726 http://dx.doi.org/10.1177/17562848211035670 |
Ejemplares similares
-
Prevalence and risk factors of mental distress in China during the outbreak of COVID‐19: A national cross‐sectional survey
por: Wu, Mindan, et al.
Publicado: (2020) -
Homologous genes shared between probiotics and pathogens affect the adhesion of probiotics and exclusion of pathogens in the gut mucus of shrimp
por: Sha, Yujie, et al.
Publicado: (2023) -
Serum apolipoprotein B-to-apolipoprotein A1 ratio is independently associated with disease severity in patients with acute pancreatitis
por: Wu, Jiayuan, et al.
Publicado: (2019) -
Compound Probiotics Improve the Diarrhea Rate and Intestinal Microbiota of Newborn Calves
por: Liu, Bo, et al.
Publicado: (2022) -
Host-derived bacillus spp. as probiotic additives for improved growth performance in broilers
por: Wang, Bei, et al.
Publicado: (2022)